A randomized, open label, cross-over comparative study of irbesartan/hydrochlorothiazide and irbesartan in the treatment of mild to moderate hypertension.

Trial Profile

A randomized, open label, cross-over comparative study of irbesartan/hydrochlorothiazide and irbesartan in the treatment of mild to moderate hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2009

At a glance

  • Drugs Irbesartan; Irbesartan/hydrochlorothiazide
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Nov 2008 Actual patient number (60) added as reported by ClinicalTrials.gov.
    • 06 Nov 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top